Clinical Trial Update: Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of fulvestrant and everolimus in advanced/metastatic breast cancer after aromatase inhibitor failure; the trial is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Afinitor (everolimus)
• Faslodex (fulvestrant)

Snippet

Sponsor: Mara Chambers | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-12-31